Navigation Links
GVSU study on gender: Who counts as a man and who counts as a woman
Date:10/28/2013

ALLENDALE, Mich. Gender is no longer determined solely by biological factors, according to a new study by a Grand Valley State University researcher whose article, "Doing Gender, Determining Gender: Transgender People, Gender Panics, and the Maintenance of the Sex/Gender/Sexuality System," was recently published in Gender & Society.

Laurel Westbrook, assistant professor of sociology at Grand Valley State, and Kristen Schilt, assistant professor of sociology at the University of Chicago, examined various case studies and found that biological factors, such as genitals and chromosomes, used to be the ultimate determiner of gender, but that is slowly changing.

"We explore the criteria for determining who is a 'man' and who is a 'woman' in sex-segregated spaces," said Westbrook. "We are at an interesting point in the history of gender, where people are torn between valuing self-identity and believing that biology determines gender. Our study explores that change in the gender system."

Westbrook examined case studies involving public debates over the expansion of transgender employment rights, policies determining eligibility of transgender people for competitive sports, and proposals to remove the genital surgery requirement for a change of sex marker on birth certificates.

"Transgender equality has never been more visible as a key issue than it is today, and with the development of every new trans-supportive law or policy, there typically follows an outbreak of criticism," said Westbrook. "In our analysis, we find that these moments, which we term 'gender panics,' are the result of a clash between two competing cultural ideas about gender identity: a belief that gender is determined by biology versus a belief that a person's self-identity in terms of gender should be validated. These gender panics frequently result in a reshaping of the language of such policies so that they require extensive bodily changes before transgender individuals have access to particular rights."

These gender panics reveal the criteria for who counts as a woman and a man in our society, said Westbrook. The study shows that the criteria for determining gender the practice of placing others in gender categories are not the same across all social spaces. While self-identity is sufficient in many circumstances, such as the workplace, people are more likely to believe that biology determines gender in sex-segregated spaces.

"In the controversies we examined, it is access to bathrooms, locker rooms, and sports teams at the center of gender panics," said Westbrook. "Moreover, not all sex-segregated spaces are policed equally. Because of beliefs that women are inherently vulnerable, particularly to unwanted heterosexual advances, it is women's spaces at the center of these debates. Thus, with these controversies, much of the discussion is about a fear of 'male' bodies in 'women's' spaces."

Westbrook said as a result of these fears, transgender rights policies are often discarded or altered in ways that force transgender people to conform to normative ideas of gendered bodies in order to access public facilities and activities that fit their identities.


'/>"/>

Contact: Laurel Westbrook
westbrol@gvsu.edu
510-541-7378
Grand Valley State University
Source:Eurekalert

Related medicine news :

1. A large, observational study of common gout treatment allopurinol shows less than half of patients reach recommended treatment goal
2. Illinois Workers’ Compensation Fee Schedule Changes Result in Lower Prices Paid; Costs of Medical Payments Decreasing, Says New Study
3. Study finds new genetic error in some lung cancers
4. Exhaled breath biomarker may detect lung cancer, study presented at Chest 2013
5. Headaches in lupus patients not linked to disease activity study says
6. New study examines link between pregnancy weight gain, autism spectrum disorders
7. 11 new genetic susceptibility factors for AD discovered through the largest study
8. Young people report worse fibromyalgia than older patients, Mayo Clinic study shows
9. DrugRisk Alert: Pradaxa Leads Study of Complication Reports to FDA
10. Multicenter Study Led by Texas Children's Hospital & Baylor College of Medicine Finds Prenatal Diagnosis & Birth Location May Significantly Improve Neonatal HLHS Survival
11. Antibiotic Resistance 2013: A Global Market Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... , ... Axiad IDS , a leading provider of trusted identities for ... company a “Top 25 Cybersecurity Companies 2017.” Axiad IDS received this honor ... proactively address potential cybersecurity threats before they happen. The annual list of ...
(Date:5/23/2017)... ... , ... New England Journal Of Medicine Confirms Viability of Rory’s Regulations and ... Staunton Foundation Calls on Health & Human Services, Tom Price to Adopt Rory’s Regulations ... today reported on a new study released on May 21, 2017 in the New ...
(Date:5/23/2017)... ... 23, 2017 , ... The Gallery of Cosmetic Surgery, founded ... to announce a new treatment option called Vivace Microneedling. This treatment option is ... body through a virtually pain-free, non-surgical treatment. Vivace Microneedling combines a state-of-the-art, best-in-class ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... video chat as a standard feature on its secure clinical communication platform. The ... voice to video depending on the type and urgency of a situation. ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... treatment using the SPEED System™ Orthodontics, with or without a referral, from the ... in El Segundo, CA, who is skilled in providing patients with the custom, ...
Breaking Medicine News(10 mins):
(Date:5/22/2017)... MAITLAND, Fla. , May 22, 2017 /PRNewswire/ ... industry as a whole continue to make the ... evidence becomes increasingly important for ensuring positive patient ... Key industry stakeholders are shifting focus away from ... results and effects of long-term specialty drug therapy ...
(Date:5/18/2017)... N.J. , May 17, 2017  Bayer announced ... oncology portfolio will be presented at the 53 rd ... Oncology (ASCO), taking place June 2-6 in ... presented at ASCO span prostate, colorectal, liver and thyroid ... analysis from the Phase II CHRONOS-1 trial of copanlisib ...
(Date:5/15/2017)... Enterin Inc., a privately-held CNS pharmaceutical company based ... to treat Parkinson,s disease (PD), has enrolled the first patient ... randomized, controlled, multicenter study involving patients with PD and taking ... over a 9-to-12-month period. The first stage is open label ... Participating sites include Denver , ...
Breaking Medicine Technology: